Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Extended-release oxycodone[1] Oxycodone (Oxycodone Hydrochloride Immediate-release)[1] Oxycodone (Oxycodone) 💬 [3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
2OXYCODO----[1] 6 💬
3Oxycodone[1] Oxycodone (Oxycodone Hydrochloride Immediate-release)[1] Oxycodone (Oxycodone) 💬 [3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[5] 6, 13, 70, 226, 298 💬
4Oxycodone Depot ”Sandoz”, depot tablets[1] Oxycodone (Oxycodone Hydrochloride Immediate-release)[1] Oxycodone (Oxycodone) 💬 [3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 298 💬
5OXYCODONE HYDROCHLORIDE[1] Oxycodone (Oxycodone Hydrochloride Immediate-release)[1] Oxycodone (Oxycodone) 💬 [3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[4] 6, 70, 226, 298 💬
6Oxycodone naloxone prolonged release tablets[2] Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
7Oxycodone Orion[1] Oxycodone (Oxycodone Hydrochloride Immediate-release)[1] Oxycodone (Oxycodone) 💬 [3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 70 💬
8Oxycodone/naloxone prolonged release t[3] Manganese citrate,
Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
9Oxycodone/Naloxone Prolonged Release tablets[2] Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
10Oxycodone/naloxone prolonged release tablets 10 mg /5 mg[3] Manganese citrate,
Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
11Oxycodone/naloxone prolonged release tablets 10/5 mg[3] Manganese citrate,
Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
12Oxycodone/naloxone prolonged release tablets 20 mg /10 mg[3] Manganese citrate,
Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
13Oxycodone/naloxone prolonged release tablets 20/10 mg[3] Manganese citrate,
Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
14Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg[3] Manganese citrate,
Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
15Oxycodone/naloxone prolonged release tablets 5/2.5 mg[3] Manganese citrate,
Naloxone,
Oxycodone (Oxycodone Hydrochloride Immediate-release)		[2] Oxycodone (Oxycodone),
Naloxone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
16Oxycodonhydrochlorid ”Lannacher”, depot tablets----[1] 298 💬
17PR Oxycodone[1] Oxycodone (Oxycodone Hydrochloride Immediate-release)[1] Oxycodone (Oxycodone) 💬 [3] OPRD1,
OPRK1,
OPRM1 💬 		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬